Devices › Device types
FDA product code OTP · class 3 · Obstetrics/Gynecology
Mesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed: medical device reports filed with FDA
11,655 reports carry this product code, 2007–2026; 30 brands with a page.
- 11,655
- reports with this product code
- 0% of all MAUDE reports
- 9
- reports, 12 months to August 2026
- 33 in the 12 months before
- 4.1%
- classified as malfunction
- 62.3% across all reports
- 2.2%
- classified as death, as reported
- 0.9% across all reports
Product code OTP is FDA's classification for "Mesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed" (obstetrics/Gynecology panel), a class 3 device. 11,655 medical device reports carry this product code, 0% of the MAUDE database, from December 2007 to August 2026.
9 reports arrived in the 12 months to August 2026, down 73% from 33 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (93.6%), malfunction (4.1%) and death (2.2%). 30 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Ethicon | 5,320 | 45.6% |
| Boston Scientific - Marlborough | 1,819 | 15.6% |
| C R Bard Covington | 1,153 | 9.9% |
| Sofradim Production | 341 | 2.9% |
| American Medical Systems Mn | 321 | 2.8% |
| American Medical Systems | 306 | 2.6% |
| Bard Shannon | 220 | 1.9% |
| Ethicon Sarl | 153 | 1.3% |
| C R Bard | 129 | 1.1% |
| C R Bard Covington -1018233 | 108 | 0.9% |
| Boston Scientific - Spencer | 39 | 0.3% |
| Sofradim Production Sas | 38 | 0.3% |
| Boston Scientific | 24 | 0.2% |
| Coloplast A/S | 12 | 0.1% |
| Cook Biotech | 12 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Material erosion | 5,195 | 44.6% |
| Insufficient device problem information | 604 | 5.2% |
| Detachment of device component | 435 | 3.7% |
| Migrationthe device moved from where it was placed | 295 | 2.5% |
| Device operates differently than expectedthe device behaved unexpectedly | 172 | 1.5% |
| Breakthe device broke | 164 | 1.4% |
| Detachment of device or device componentpart of the device came off | 159 | 1.4% |
| Migration or expulsion of device | 149 | 1.3% |
| Extrusion | 140 | 1.2% |
| Other (for use when an appropriate device code cannot be identified) | 102 | 0.9% |
| Retraction problem | 43 | 0.4% |
| Patient-device incompatibilitythe device did not suit the patient | 31 | 0.3% |
| Defective devicethe device was defective | 23 | 0.2% |
| Material protrusion/extrusion | 23 | 0.2% |
| Patient device interaction problem | 14 | 0.1% |
| Torn material | 10 | 0.1% |
| Malposition of device | 9 | 0.1% |
| Material separation | 8 | 0.1% |
| Entrapment of device | 7 | 0.1% |
| Material split, cut or torn | 7 | 0.1% |
Questions about mesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed reports
What is product code OTP?
FDA's classification code for "Mesh, surgical, synthetic, urogynecologic, for pelvic organ prolapse, transvaginally placed", class 3, reviewed by the obstetrics/Gynecology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
11,655 reports through August 2026, 9 of them in the latest 12 months.
Which brands appear most often?
Gynecare Prolift Total Pelvic Floor Repair System (1,186), Prolift Pelvic Floor Repair (1,142), Uphold Lite (869), Pinnacle Pelvic Floor Repair Kits (835) and Uphold Vaginal Support System (708). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.